Vinzenz Von Paul Kliniken gGmbH — Clinical Trial Site

12 Registered trials

4 Currently recruiting

Organisation

Vinzenz Von Paul Kliniken gGmbH

Location

Stuttgart, Germany

Identifier

ORG-100042522

Address

Böheimstraße 37, Süd, 70199, Germany

Departments

-
Gynäkologie und Geburtshilfe
Klinik für Gynäkologie und Geburtshilfe
Klinik für Gynäkologie und Geburtshilfe Ortenau-Klinikum Offenburg-Gengenbach
Klinik für Innere Medizin 3
Klinik für Strahlentherapie und Palliativmedizin
Marienhospital GmbH
N/A
Onkologie
Zentrum für Innere Medizin I
Zentrum für Innere Medizin II

Clinical trials at this site (12)

Search interface

Phase II study evaluating the addition of elacestrant, an oral selective estrogen receptor degrader (SERD), to standard-of-care olaparib in … Recruiting

2023-504925-38-00 patients with hormone receptor (HR)-positive, HER2-nega 4 2024-12-10
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer … Recruiting

2024-512279-10-00 Triple Negative Breast Cancer 5 2024-11-25
MK-1084 with Pembrolizumab in 1L Locally Advanced or Metastatic NSCLC With KRAS G12C Mutations and PD-L1 ≥50% Recruiting

2023-507776-42-00 Non-small cell lung cancer 5 2024-11-14
PACCELIO - FDG-PET based small volume accelerated immuno chemoradio-therapy in locally advanced NSCLC Recruiting

2023-510506-41-00 Locally advanced, unresectable non-small-cell lung canc 4 2024-04-15
A Study of Dato-DXd With or Without Durvalumab Versus Investigator’s Choice of Therapy in Patients With Stage I-III Triple-negative Breast C… Ended

2023-505552-22-00 Stage I-III Triple-negative Breast Cancer with residual 5 2023-02-24
Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study (ROSE) Ended

2022-503028-29-01 Patients with stage IV EGFR-mutation positive NSCLC tar 4 2021-12-14
A Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Receiving Concurrent Definitive Chemoradiotherap… Ended

2022-501531-16-00 esophageal carcinoma 5 2020-01-24
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CV… Ended

2023-507846-96-00 Type 2 Diabetes Mellitus 5 2020-06-19
First-line chemotherapy plus pembrolizumab and olaparib for BRCA nonmutated advanced EOC Ended

2022-502124-52-00 Advanced epithelial ovarian cancer 5 2018-12-18
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
HD21 Ended

2024-518022-33-00 Advanced Stage of Hodgkin Lymphoma 5 2016-07-15
A Study to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and … Ended

2023-504034-22-00 Chronic Lymphocytic Leukemia (CLL) 5 2014-12-18